Rep. Michael Guest

Maddy summaryHRES 864 is a ceremonial resolution honoring U.S. veterans on Veterans Day 2025. It does not create new laws or policies but formally recognizes veterans' service and sacrifice, calling on all Americans to observe Veterans Day. The resolution references historical context about Veterans Day's origins (from Armistice Day to honoring all veterans) but contains no concrete policy changes. It directly addresses the general public, urging them to participate in the observance. As a non-binding resolution, it affects no specific individuals or groups through legislative action.

Maddy summaryHRES 866 is a non-binding House resolution condemning the systematic persecution of Christians in Nigeria by groups like Boko Haram and Fulani militants, and criticizing Nigeria's government for failing to protect Christian communities or acknowledge the violence. It calls on the U.S. government to support President Trump in using diplomatic, economic, and security tools to pressure Nigeria to end impunity for attacks, protect Christians, return displaced persons, and repeal blasphemy laws. The resolution specifically demands action against religiously motivated violence, including the release of those imprisoned for their faith, and urges coordination with international partners for humanitarian aid. It does not create new laws but expresses congressional support for U.S. policy actions targeting Nigeria's religious freedom violations.

Maddy summaryHR 5969, the LABEL Act, requires abortion-inducing drugs to include specific labeling identifying both the drug dispenser's name/address and the prescriber's name. It directly affects pharmacies, clinics, and prescribers distributing these drugs by mandating this labeling on all such products. The bill prohibits states from imposing stricter labeling rules than this federal standard. It defines "abortion-inducing drug" as one intended or used to end a pregnancy (excluding drugs for miscarriage management or ectopic pregnancy treatment). This is a labeling requirement, not a restriction on drug access or use.

Maddy summaryHRES 855 is a non-binding House resolution expressing support for National Adoption Day (November 22, 2025) and National Adoption Month (November). It promotes awareness about children in foster care awaiting adoption - highlighting that 49,994 U.S. children were waiting for adoptive families in 2023 - and encourages the public to consider adoption. The resolution recognizes that every child deserves a permanent, loving family and urges Americans to support this goal throughout November and the year. As a symbolic gesture, it does not create new laws or policies.

Maddy summaryThis bill ensures that critical firearm-related government operations continue during federal shutdowns. It designates background checks (via the FBI's National Instant Criminal Background Check System), Bureau of Alcohol, Tobacco, Firearms and Explosives enforcement, and firearm export licensing (handled by Commerce and State Departments) as essential services that must remain operational. These functions would be treated as "excepted" under federal law, meaning their employees would continue working even if other government services halt. The bill affects how background checks and firearm export licenses are processed during shutdowns but does not change gun ownership laws or eligibility.

Maddy summaryHRES 803 is a non-binding resolution urging the FDA to reassess the safety of all chemical abortion drugs based on recent independent studies. It specifically requests the FDA reevaluate safety data and publicly release a full safety review including real-world complications. The resolution does not change laws or create new requirements but asks the FDA to consider findings that claim complication rates are 22 times higher than current reports. This resolution directly addresses the FDA's regulatory oversight of these drugs, not other entities or policies.

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).

Maddy summaryThis bill requires the FDA to reinstate the 2011 safety program for mifepristone (the drug sold as Mifeprex) and bans its importation into the U.S. It creates federal liability for harm caused by illegal importers of the drug, allowing lawsuits for bodily injury or mental health harm resulting from unauthorized importation. The law applies specifically to telehealth providers, pharmacies, or others who knowingly import mifepristone across state lines. It takes effect 90 days after enactment.

Maddy summaryHR 5573, the Combatting Fentanyl Poisonings Act of 2025, creates three federal grant programs to address fentanyl-related harms. It funds state/local law enforcement to target illegal social media sales of controlled substances (including fentanyl-laced counterfeit pills) and provides education for schools and parents about fentanyl risks. Nonprofits receive grants up to $50,000 to run public awareness campaigns, produce educational materials, and offer counseling for families affected by fentanyl deaths - though funds cannot cover most harm reduction supplies (only naloxone is permitted). The bill allocates $10 million for law enforcement programs, $3 million for awareness grants, and $2 million for officer safety equipment like fentanyl test strips and naloxone training.